Data as of May 24
| -1.18 / -1.72%|
The 5 analysts offering 12-month price forecasts for USANA Health Sciences Inc have a median target of 54.00, with a high estimate of 80.00 and a low estimate of 49.00. The median estimate represents a -19.80% decrease from the last price of 67.33.
The current consensus among 5 polled investment analysts is to Hold stock in USANA Health Sciences Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.